Advertisement

Erratum to: “EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma” [J Hepatol 2012;56:908–943]

Published:April 09, 2012DOI:https://doi.org/10.1016/j.jhep.2012.03.006

      Linked Article

      • EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
        Journal of HepatologyVol. 56Issue 4
        • Preview
          EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies recommended for patients with this type of cancer. This is the first European joint effort by the European Association for the Study of the Liver (EASL) and the European Organization for Research and Treatment of Cancer (EORTC) to provide common guidelines for the management of hepatocellular carcinoma. These guidelines update the recommendations reported by the EASL panel of experts in HCC published in 2001 [1].
        • Full-Text
        • PDF
        Open Access
      Fig. 3 was incomplete for BCLC stage A, and it has been corrected as per below. Patients at BCLC stage A and single tumors can be evaluated for surgical resection.
      Figure thumbnail gr1
      Fig. 3Updated BCLC staging system and treatment strategy, 2011.